Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: -0.05 (-1.52%)
Spread: 0.10 (3.125%)
Open: 3.30
High: 3.30
Low: 3.25
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: IS Solutions, Netservices, Plant Health Care...

Mon, 14th Sep 2009 09:51

Higher revenues helped software services group IS Solutions post broadly unchanged profits in the six months to June 30.Pre-tax profits for the period totalled £184,000, compared with £189,000 the previous year, as revenues soared to £5.12m from £3.64m. During the year, the company completed the purchase of headquarters on Sunbury on Thames and invested in establishing a branch office in the Indian sub-continent.Business communications group Netservices expects to post an operating loss of about £200,000 for the year to August 31 due to time it will take to develop relationships with clients.Depressed agricultural markets resulted in widening losses at natural plant supplement supplier Plant Health Care (PHC). Revenue in the six months to June 30 fell to $5.5m from $7.8m over the same period the previous year and pre-tax losses grew to $3.9m from $3.3m. PHC said that it had received large orders from the seed giant Monsanto for its Harpin seed treatment.China Wonder reported a drop in half year profits despite a 21% rise in sales revenue and said it continues to actively seek expansion opportunities both in the People's Republic of China and the United Kingdom. Pre-tax profit fell to £220,053 in the six month ended 30 June from £253,546 last time. Sales revenue for the period was £2.11m when compared to the £1,743,863 of sales for the same period in 2008.Expansion into Brazil and Germany helped Publishing Technologies, which provides online systems and management software to academic publishers, narrow losses sharply in the six months to June 30. Pre-tax losses totalled £99,000 for the period, compared with £299,000 for the same period the previous year. Revenue climbed to £7.7m from £7.3m.Environmental Recycling cut net losses from £1.8m to £0.54m in the half-year to June, on sales up to £427,000 (£179,000). The increasing recycling agenda has led to a considerable number of enquiries and negotiations in respect of the application of the PIM Process in various sectors, it said. The one major difficulty that remains is the ongoing litigation with the group's former CEO in Kyrgyzstan, it added.Intelligent Environments has signed a three year rolling contract with Home Retail priced on IE's transactional revenue model. IE will deliver a comprehensive electronic card statement system for Argos and Homebase store card customers.Biotech ValiRx has created a new wholly owned trading subsidiary, ValiMedix, to distribute a range of new diagnostic screening products acquired from Pasante Healthcare. The new diagnostic screening products principally comprise the Self Check screening products which allow an individual to check for potential health problems at an early stage. International Brand Licensing slipped into losses in the half year to June, losing £170,000 against a profit of £248,000. IBL said the figures should be considered against the backdrop of a very depressed sporting goods industry and a big exceptional gain last time. Timestrip, which makes labels indicating how long containers for food have been unsealed, saw higher revenues and reduced losses in the six months to June 30.. Revenues in the six months to June 30 climbed to £386m from £268m as losses narrowed to £453m from £697m.The firm also reported positive feedback from NHS trials of its TimeStripPlus technology which is used to show if a temperature sensitive product such as a drug has been exposed to incorrect temperatures.Angel Mining lost £1.5m in the 12 months ended 28 February versus £4.2m in 2008 following the reversal of impairment provisions of £3.2m linked to exploration costs at Black Angel in Greenland.The company, formerly known as Angus & Ross, wants to get Nalunaq in the south of Greenland into production this year then try and get the Black Angel mine producing by the end of 2010.Titanium Resources tumbled on Monday as it said sales fell to $19.8m in the six months ended 30 June from $32.5m previously, although some of that was due to the sale of a Bauxite mine last year.The loss after tax narrowed to $4.95m from $20.2m a year earlier as the cost of sales fell by 52% to $20.7m. 'We believe the company is on track to achieve operating profitability for H2 2009,' said boss John Sisay.Superconductor energy technology firm Zenergy Power has reported a big drop in revenue for the first half of 2009 to €0.2m from €1m and an increase in losses to £5m from £2.6m before.But it says continuing growth in its order backlog, €2.3m at the end of June, will 'smooth' its revenue recognition over reporting periods. 'However, in the short-term we expect lumpiness to be a feature of our revenue generation and this is certainly the case with our 2009 reporting.'Mobile marketing and advertising group Velti grew pre-tax profit to €2.7m in the six months to 30 June, up from €1.6m in 2008 on revenue 36% higher to €21.7m.'During the remainder of 2009 we will continue to build up momentum and grow the Company in a sustainable way with a strong focus on cash flow,' said chief executive Alex Moukas.Online retailer of ethical fashion and lifestyle products Adili saw pre-tax losses widen in the year to 30 April 2009 from £1.59m to £1.90m on sales that rose from £0.35m to £0.55m. Sales for the first five months of the current financial year are up 29% on a year earlier.The first half of 2009 saw loss before tax widen at biopharmaceutical contract manufacturer Angel Biotechnology to £0.52m from £0.46m, but revenue improved to £0.6m from £0.48m. 'Due to the structure of contracts we currently have, revenue recognition is necessarily delayed resulting in lower figures for H1 [first half] 2009 than might have been expected with the value of business signed. This situation is expected to be rectified in H2 [second half] 2009 and into 2010 as the revenues from these projects are recognised,' the company said.Security and fire alarm firm Westminster Group has won a tolling 12-month contract to provide 24-hour bodyguard protection to a rich individual and his family in the Middle East. The contract is worth £0.54m.
More News
24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

Read more
6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

Read more
1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

Read more
16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

Read more
8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

ValiRx Delays Annual Results Amid Covid-19 Pandemic

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

Read more
29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

Read more
29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

Read more
27 May 2020 14:20

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

Read more
7 May 2020 14:45

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

Read more
4 May 2020 16:18

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.